VALBONNE, France--(BUSINESS WIRE)-- Regulatory News: TxCell SA (Paris:TXCL) (FR0010127662 TXCL), a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic ... CNBC, 13 hours ago
TxCell : Mise à disposition du document de référence 2015 - Stockhouse Canada, 1 day ago
May 25 Txcell SA : * Txcell obtains authorization from European regulatory authorities to restart Ovasave Phase IIb clinical trial Source text for Eikon: Further company coverage: (Gdynia Newsroom) Our top photos from the lastReuters UK, 13 hours ago Txcell obtains authorization to restart Ovasave phase IIb clinical trial Reuters UK, 12 hours ago
Diamonds and gems Petra Diamonds to receive 15% of sales proceeds. | 25 May 2016 13:18 Main image courtesy ofChristie's Images LTD. 2016. A 24.18 carat blue diamond is set to fetch between $23 million and $29 million at auction early ...Mineweb, 14 hours ago Petra Diamonds fancy intense blue diamond goes on auction MiningReview.com, 16 hours ago Christie's to sell 24.18 ct Cullinan Dream diamond for up to $29m Mining Weekly, 19 hours ago Petra Diamonds Limited Auction of the Cullinan Dream Blue Diamond ADVFN UK, 21 hours ago
Wed, 25/05/2016 - 16:21 Tags : Ergomed is acquiring Haemostatix from a group of UK-based VC investors including Albion Ventures, Catapult Ventures, Esperante, as well as Nesta and the Wellcome Trust for an initial consideration of GBP8.0 ...Private Equity Wire, 13 hours ago Albion Ventures sells Haemostatix to Ergomed ACQ Magazine, 17 hours ago
LONDON (Alliance News) - Petra Diamonds PLC is set to book a sizeable profit from the sale of the latest exceptional diamond to come out of its Cullinan mine in South Africa when the Cullinan Dream is auctioned off in New York next month.Petra ...London South East, 13 hours ago
25/05/2016 1:59pm UK Regulatory (RNS & others) E-Therapeutics (LSE:ETX) Intraday Stock Chart Today : Wednesday 25 May 2016 TIDMETX RNS Number : 3084Z e-Therapeutics plc 25 May 2016 e-Therapeutics plc ('e-Therapeutics' or ...ADVFN UK, 14 hours ago Result of AGM MoneyAM, 15 hours ago e-Therapeutics plc AGM Statement ADVFN UK, 22 hours ago ValiRx PLC Final Results ADVFN UK, 6 days ago
Home » tips » / no comments A new study from Örebro University, published in Science Signaling today, shows that heart medication reduces the build-up of plaque in the brain's blood vessels in mice. The question is if this is true also ...HealthMediciNet.com, 14 hours ago
The Federal Highway Administration (FHWA) approved a revised environmental assessment for the bridge, which will extend from the southern end of the Pea Island National Wildlife Refuge over the Pamlico Sound into Rodanthe. The NC 12 Rodanthe ...Bridge Design & Engineering, 14 hours ago
GE Renewable Energy has introduced a North American version of its new 3MW wind turbine platform. The turbine platform, which first debuted in Europe last November, now includes a new 60 Hz version of the 3.4MW machine, with rotor diameter options ...Windtech International, 15 hours ago GE Rolls Out New 3 MW North American Turbine Platform North American Windpower, 1 day ago GE expands offshore wind platform Today's Energy Solutions, 1 day ago GE unveils 3.4MW turbine variants for North American wind market RechargeNews.com, 2 days ago
NLS Pharma Announces Submission of Investigational New Drug IND Application to FDA for Its Controlled-Release Mazindol for the Treatment of Adults...
NLS Pharma Announces Submission of Investigational New Drug IND Application to FDA for Its Controlled-Release Mazindol for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder ADHD By a News Reporter-Staff News Editor at Biotech ...Pharmacy Choice, 17 hours ago IND submitted to study mazindol for ADHD in adults Healio, 1 week ago NLS Pharma Submits IND for ADHD Drug PharmaceuticalProcessing, 1 week ago NLS Pharma submits IND to FDA for Mazindol to treat ADHD Pharmaceutical Business Review, 1 week ago
on your WebpageAdd Widget >Get your members hooked!